---
title: Webinar | Evaluation of HER2-low and ultralow status of advanced breast carcinomas
description: Watch this webinar to discover how digital pathology with AI evaluation is a more sensitive method for HER2-low assessment.
image: https://www.aiforia.com/hubfs/Website%20Assets/Webinars/Webinars%20LP%20thumbnails/Webinar_HER%202%20low_thumbnail%201.png
---

![](https://www.aiforia.com/hubfs/Avidly2020_Theme_assets/anime/Neural-network-complex-image.svg)

# On-demand webinar Evaluation of HER2-low and ultralow status of advanced breast carcinomas

Watch this webinar to discover how digital pathology with AI evaluation is a more sensitive method for HER2-low assessment. Dr. Anikó Kovács (Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden) presents findings from a retrospective study on the HER2-low status of advanced breast carcinomas in core biopsies. 

The aim of the study was to:

- compare the outcome of HER2 scoring using conventional microscopy, digital pathology, and AI.
- assess changes in HER2-low status in core biopsies, matching operation specimens, and their distant metastases.

Learn more about the findings and how AI can help determine a more accurate HER2-low status, providing an exact percentage of each HER2 score within seconds with high accuracy.

![Aniko Kovacs_portrait_square](https://www.aiforia.com/hs-fs/hubfs/Website%20Assets/Speaker%20Images/Aniko%20Kovacs_portrait_square.png?width=150&name=Aniko%20Kovacs_portrait_square.png)

**Anikó Kovács, MD, PhD** Associate Professor, Pathologist, and Lecturer at Sahlgrenska University Hospital

- Has worked in research in Sweden for the past 23 years
- Breast cancer research at the Leicester University in the UK
- Research background also in Japan (Kitasato University) and Hungary

![Rute P_portrait_500x500px](https://www.aiforia.com/hs-fs/hubfs/Website%20Assets/Team%20Portraits/Team%20portraits_500x500px/Rute%20P_portrait_500x500px.jpg?width=150&name=Rute%20P_portrait_500x500px.jpg)

**Rute Pedrosa, PhD** Senior Field Application Scientist, Aiforia Technologies

- Has worked at Aiforia for 2.5 years
- PhD at Erasmus University Rotterdam, focusing on the pathogenesis of brain metastatic disease

## Watch the on-demand webinar

On-demand webinar

## Evaluation of HER2-low and ultralow status of advanced breast carcinomas

Intro to Aiforia

00:25

Presentation by Dr. Anikó Kovács

04:18

Q&A

31:36

 Your browser does not support the video tag.